Evidence map›Paper›PMID 41012175›Full record

ArticleVaccines2025

Safety and Immunogenicity of Single-Dose of Adsorbed Tetanus Vaccine in Adults Aged 18-44 Years: Randomized, Double-Blind, Positive-Controlled Phase I/III Clinical Trial.

Zhiqiang Xie, Liyong Yuan, Yaping Qiao, Wangyang You, Yurong Li, Taotao Zhu, Wei Zhang, Lili Huang, Jiebing Tan, Xiaocan Jia and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Zhiqiang XieHenan Provincial Center for Disease Control and Prevention, Zhengzhou 450016, China.
Liyong YuanNational Institutes for Food and Drug Control, Beijing 102629, China.
Yaping QiaoSinovac Holding Group Co., Ltd., Beijing 100085, China.ORCID 0000-0002-0386-1071
Wangyang YouHenan Provincial Center for Disease Control and Prevention, Zhengzhou 450016, China.
Yurong LiSinovac Holding Group Co., Ltd., Beijing 100085, China.ORCID 0000-0001-6851-0435
Taotao ZhuSinovac Holding Group Co., Ltd., Beijing 100085, China.
Wei ZhangHenan Provincial Center for Disease Control and Prevention, Zhengzhou 450016, China.
Lili HuangHenan Provincial Center for Disease Control and Prevention, Zhengzhou 450016, China.
Jiebing TanHenan Provincial Center for Disease Control and Prevention, Zhengzhou 450016, China.
Xiaocan JiaDepartment of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou 450001, China.ORCID 0000-0003-0895-2957
Zhe LiNational Institutes for Food and Drug Control, Beijing 102629, China.
Feng XueSinovac Life Sciences Co., Ltd., Beijing 102601, China.
Xiaojuan LianSinovac Holding Group Co., Ltd., Beijing 100085, China.
Yanxia WangHenan Provincial Center for Disease Control and Prevention, Zhengzhou 450016, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

clinical trialimmunogenicitysafetytetanusvaccine

Identifiers

PMID41012175
PMCPMC12474341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.